Home
>
National Drug Code (NDC)
>
Labetalol HCl
Labetalol HCl - 51079-929-20 - (Labetalol HCl)
Drug Information of Labetalol HCl
| Product NDC: | 51079-929 |
| Proprietary Name: | Labetalol HCl |
| Non Proprietary Name: | Labetalol HCl |
| Active Ingredient(s): | 200 mg/1 & nbsp; Labetalol HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Labetalol HCl
| Product NDC: | 51079-929 |
| Labeler Name: | UDL Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075113 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110506 |
Package Information of Labetalol HCl
| Package NDC: | 51079-929-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-929-20) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-929-01) |
NDC Information of Labetalol HCl
| NDC Code | 51079-929-20 |
| Proprietary Name | Labetalol HCl |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-929-20) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-929-01) |
| Product NDC | 51079-929 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Labetalol HCl |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110506 |
| Marketing Category Name | ANDA |
| Labeler Name | UDL Laboratories, Inc. |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
